GlassScriptPhysician profile
Kari L Hueni
NPI 1134452337
$764.05
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $609 · 2022: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $239.73 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $111.55 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.02 | 2021 | |
| Novo Nordisk INC | $53.91 | 2021-2022 | |
| Abbott Laboratories | $49.50 | 2021 | |
| Lilly USA, LLC | $39.53 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.08 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $24.15 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.51 | 2022 | |
| Hologic Sales and Service, LLC | $18.51 | 2022 | |
| Antares Pharma, INC. | $17.65 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.79 | 2021 | |
| Lucid Diagnostics INC. | $16.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.67 | 2021 | |
| Medtronic, INC. | $11.48 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $11.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Hueni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.